Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2024 Filed Apr 2, 2024 21:00 UTC |
ANASTASIO CURTDirector
|
Exercise / conversionRestricted Shares · Derivative | 6,419 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040316 · ownership.xml · derivative · entry 3 ANASTASIO CURT · CIK 0001032097 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,419 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024. F2 · derivative.expiration_date: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:00 UTC |
ANASTASIO CURTDirector
|
GrantRestricted Shares · Derivative | 9,317 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040316 · ownership.xml · derivative · entry 2 ANASTASIO CURT · CIK 0001032097 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,317 Underlying: Common Stock · 9,317 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance. F1 · derivative.expiration_date: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:00 UTC |
ANASTASIO CURTDirector
|
Exercise / conversionCommon Stock | 6,419 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040316 · ownership.xml · nonDerivative · entry 1 ANASTASIO CURT · CIK 0001032097 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:02 UTC |
Carnes Martha Z.Director
|
Exercise / conversionRestricted Shares · Derivative | 6,419 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040323 · ownership.xml · derivative · entry 3 Carnes Martha Z. · CIK 0001678397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,419 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024. F2 · derivative.expiration_date: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:02 UTC |
Carnes Martha Z.Director
|
GrantRestricted Shares · Derivative | 9,317 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040323 · ownership.xml · derivative · entry 2 Carnes Martha Z. · CIK 0001678397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,317 Underlying: Common Stock · 9,317 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance. F1 · derivative.expiration_date: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:02 UTC |
Carnes Martha Z.Director
|
Exercise / conversionCommon Stock | 6,419 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040323 · ownership.xml · nonDerivative · entry 1 Carnes Martha Z. · CIK 0001678397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,011 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 17:10 UTC |
Straughen MichaelDirector
|
Exercise / conversionRestricted Shares · Derivative | 6,419 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040347 · ownership.xml · derivative · entry 4 Straughen Michael · CIK 0001677384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,419 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024. F2 · derivative.expiration_date: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 17:10 UTC |
Straughen MichaelDirector
|
GrantRestricted Shares · Derivative | 9,317 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040347 · ownership.xml · derivative · entry 3 Straughen Michael · CIK 0001677384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,317 Underlying: Common Stock · 9,317 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance. F1 · derivative.expiration_date: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 17:10 UTC |
Straughen MichaelDirector
|
Exercise / conversionCommon Stock | 6,419 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040347 · ownership.xml · nonDerivative · entry 2 Straughen Michael · CIK 0001677384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,886 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 17:10 UTC |
Straughen MichaelDirector
|
Tax withholdingCommon Stock | 3,017 | $17.13 | $51,681.21 |
DisclosureSEC source: 0000950170-24-040347 · ownership.xml · nonDerivative · entry 1 Straughen Michael · CIK 0001677384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,869 Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:05 UTC |
Klingensmith Harvey RobertDirector
|
Exercise / conversionRestricted Shares · Derivative | 6,419 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040329 · ownership.xml · derivative · entry 3 Klingensmith Harvey Robert · CIK 0001800107 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,419 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024. F2 · derivative.expiration_date: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:05 UTC |
Klingensmith Harvey RobertDirector
|
GrantRestricted Shares · Derivative | 9,317 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040329 · ownership.xml · derivative · entry 2 Klingensmith Harvey Robert · CIK 0001800107 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,317 Underlying: Common Stock · 9,317 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance. F1 · derivative.expiration_date: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:05 UTC |
Klingensmith Harvey RobertDirector
|
Exercise / conversionCommon Stock | 6,419 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040329 · ownership.xml · nonDerivative · entry 1 Klingensmith Harvey Robert · CIK 0001800107 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,645 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:12 UTC |
Temeng KwakuDirector
|
Exercise / conversionRestricted Shares · Derivative | 6,419 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040354 · ownership.xml · derivative · entry 3 Temeng Kwaku · CIK 0001846675 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,419 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024. F2 · derivative.expiration_date: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:12 UTC |
Temeng KwakuDirector
|
GrantRestricted Shares · Derivative | 9,317 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040354 · ownership.xml · derivative · entry 2 Temeng Kwaku · CIK 0001846675 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,317 Underlying: Common Stock · 9,317 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance. F1 · derivative.expiration_date: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:12 UTC |
Temeng KwakuDirector
|
Exercise / conversionCommon Stock | 6,419 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040354 · ownership.xml · nonDerivative · entry 1 Temeng Kwaku · CIK 0001846675 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,211 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:08 UTC |
Murray KatherineDirector
|
Exercise / conversionRestricted Shares · Derivative | 6,419 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040339 · ownership.xml · derivative · entry 3 Murray Katherine · CIK 0001930744 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,419 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024. F2 · derivative.expiration_date: The Restricted Shares vested at the end of a one-year vesting period ending April 1, 2024. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:08 UTC |
Murray KatherineDirector
|
GrantRestricted Shares · Derivative | 9,317 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040339 · ownership.xml · derivative · entry 2 Murray Katherine · CIK 0001930744 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,317 Underlying: Common Stock · 9,317 shares Expires not disclosed F1 · derivative.exercise_date: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance. F1 · derivative.expiration_date: The Restricted Shares will vest, without performance criteria, at the end of a one-year vesting period on April 1, 2025, subject to the terms of issuance. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 21:08 UTC |
Murray KatherineDirector
|
Exercise / conversionCommon Stock | 6,419 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-040339 · ownership.xml · nonDerivative · entry 1 Murray Katherine · CIK 0001930744 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2024 Filed Feb 15, 2024 21:10 UTC |
Tattoli Mark DamianSVP, Gen Counsel & Secretary
|
GrantPerformance Shares · Derivative | 38,002 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-015883 · ownership.xml · derivative · entry 1 Tattoli Mark Damian · CIK 0001872069 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,002 Underlying: Common Stock · 38,002 shares Expires not disclosed F1 · derivative.exercise_date: This award vests at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the "Performance Period"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. F2 · derivative.exercise_date: The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award). The number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period. F1 · derivative.expiration_date: This award vests at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the "Performance Period"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. F2 · derivative.expiration_date: The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award). The number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period. Read SEC document |
| February 15, 2024 Filed Feb 15, 2024 16:11 UTC |
Hill Christopher ScottSVP & CFO
|
GrantPerformance Shares · Derivative | 79,442 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-015888 · ownership.xml · derivative · entry 1 Hill Christopher Scott · CIK 0001641315 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,442 Underlying: Common Stock · 79,442 shares Expires not disclosed F1 · derivative.exercise_date: This award vests at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the "Performance Period"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. F2 · derivative.exercise_date: The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award). The number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period. F1 · derivative.expiration_date: This award vests at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the "Performance Period"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. F2 · derivative.expiration_date: The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award). The number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period. Read SEC document |
| February 15, 2024 Filed Feb 15, 2024 21:12 UTC |
Bruno LawrenceDirector · Chairman and CEO
|
GrantPerformance Shares · Derivative | 234,124 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-015891 · ownership.xml · derivative · entry 1 Bruno Lawrence · CIK 0001730336 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,124 Underlying: Common Stock · 234,124 shares Expires not disclosed F1 · derivative.exercise_date: This award vests at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the "Performance Period"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. F2 · derivative.exercise_date: The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award). The number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period. F1 · derivative.expiration_date: This award vests at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the "Performance Period"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. Read SEC document |
| February 15, 2024 Filed Feb 15, 2024 16:11 UTC |
Daniels KevinCAO & Treasurer
|
GrantPerformance Shares · Derivative | 8,882 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-015887 · ownership.xml · derivative · entry 1 Daniels Kevin · CIK 0001740507 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,882 Underlying: Common Stock · 8,882 shares Expires not disclosed F1 · derivative.exercise_date: Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance criteria set forth below, this award will vest at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the"Performance Period"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 55th percentile of Return On Invested Capital (ROIC) of the Bloomberg Peer Group (BPG), and 200% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 55th and 85th percentile (equivalent to 100% up to 200% of the award). F1 · derivative.expiration_date: Assuming a recipient's continued employment (or death or disability while employed) and the satisfaction of certain performance criteria set forth below, this award will vest at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the"Performance Period"). At the end of the Performance Period, 100% of the award will vest if the Company is in the top 55th percentile of Return On Invested Capital (ROIC) of the Bloomberg Peer Group (BPG), and 200% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 55th and 85th percentile (equivalent to 100% up to 200% of the award). Read SEC document |
| February 15, 2024 Filed Feb 15, 2024 16:09 UTC | GrantPerformance Shares · Derivative | 38,002 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-015879 · ownership.xml · derivative · entry 1 Gresham Gwendolyn · CIK 0001842114 · SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,002 Underlying: Common Stock · 38,002 shares Expires not disclosed F1 · derivative.exercise_date: This award vests at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the "Performance Period"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. F2 · derivative.exercise_date: The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award). The number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period. F1 · derivative.expiration_date: This award vests at the end of a three-year performance period that began on January 1, 2024 and ends on December 31, 2026 (the "Performance Period"). This award survives termination of employment due to death, disability, termination by the Company without cause or retirement by the employee upon having reached 62 years of age. In all cases, the shares will vest, if at all, at the end of the Performance Period as follows: 50% of the award will vest if the Company is in the top 35th percentile of Return on Invested Capital (ROIC) among the Bloomberg Peer Group (BPG), 100% of the award will vest if the Company is in the top 55th percentile of ROIC of the BPG, and 175% of the award will vest if the Company is in the top 85th percentile of ROIC of the BPG, as measured and determined by the Compensation Committee at the end of the Performance Period. F2 · derivative.expiration_date: The number of common shares vesting pursuant to the award will be interpolated on a straight-line basis between the 35th and 55th percentile (equivalent to 50% up to 100% of the award) and again between the 55th and 85th percentile (equivalent to 100% up to 175% of the award). The number of common shares that could vest over 100% of the award up to the maximum of 175% of the award, if any, will be reduced by one-half if absolute total shareholder return for the Performance Period is negative, as measured and determined by the Compensation Committee at the end of the Performance Period. Read SEC document |
|
| December 31, 2023 Filed Jan 3, 2024 22:50 UTC |
Tattoli Mark DamianSVP, Gen Counsel & Secretary
|
Exercise / conversionCommon Stock | 6,900 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001250 · ownership.xml · nonDerivative · entry 2 Tattoli Mark Damian · CIK 0001872069 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,092.621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 22:50 UTC |
Tattoli Mark DamianSVP, Gen Counsel & Secretary
|
Tax withholdingCommon Stock | 2,654 | $17.66 | $46,869.64 |
DisclosureSEC source: 0000950170-24-001250 · ownership.xml · nonDerivative · entry 1 Tattoli Mark Damian · CIK 0001872069 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,438.621 Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 17:43 UTC |
Hill Christopher ScottSVP & CFO
|
Exercise / conversionPerformance Shares · Derivative | 36,072 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001237 · ownership.xml · derivative · entry 4 Hill Christopher Scott · CIK 0001641315 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,072 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. The Company finished in the 81st percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2023. Excess shares that could vest above the 75th percentile are subject to an absolute total shareholder return modifier, which was negative over the relevant performance period, thereby reducing the number of such shares eligible to vest by one-half. Therefore, the performance criteria and requirements for vesting have been satisfied at 106.25% of the target award level, and such number of shares vested on December 31, 2023. F1 · derivative.expiration_date: These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. The Company finished in the 81st percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2023. Excess shares that could vest above the 75th percentile are subject to an absolute total shareholder return modifier, which was negative over the relevant performance period, thereby reducing the number of such shares eligible to vest by one-half. Therefore, the performance criteria and requirements for vesting have been satisfied at 106.25% of the target award level, and such number of shares vested on December 31, 2023. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 17:43 UTC |
Hill Christopher ScottSVP & CFO
|
Exercise / conversionCommon Stock | 36,072 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001237 · ownership.xml · nonDerivative · entry 2 Hill Christopher Scott · CIK 0001641315 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 17:43 UTC |
Hill Christopher ScottSVP & CFO
|
Tax withholdingCommon Stock | 13,870 | $17.66 | $244,944.20 |
DisclosureSEC source: 0000950170-24-001237 · ownership.xml · nonDerivative · entry 1 Hill Christopher Scott · CIK 0001641315 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,374 Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 22:40 UTC |
Bruno LawrenceDirector · Chairman and CEO
|
Exercise / conversionPerformance Shares · Derivative | 100,058 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001227 · ownership.xml · derivative · entry 3 Bruno Lawrence · CIK 0001730336 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,058 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. The Company finished in the 81st percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2023. Excess shares that could vest above the 75th percentile are subject to an absolute total shareholder return modifier, which was negative over the relevant performance period, thereby reducing the number of such shares eligible to vest by one-half. Therefore, the performance criteria and requirements for vesting have been satisfied at 106.25% of the target award level, and such number of shares vested on December 31, 2023. F1 · derivative.expiration_date: These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. The Company finished in the 81st percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2023. Excess shares that could vest above the 75th percentile are subject to an absolute total shareholder return modifier, which was negative over the relevant performance period, thereby reducing the number of such shares eligible to vest by one-half. Therefore, the performance criteria and requirements for vesting have been satisfied at 106.25% of the target award level, and such number of shares vested on December 31, 2023. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 22:40 UTC |
Bruno LawrenceDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 100,058 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001227 · ownership.xml · nonDerivative · entry 2 Bruno Lawrence · CIK 0001730336 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 202,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 22:40 UTC |
Bruno LawrenceDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 38,473 | $17.66 | $679,433.18 |
DisclosureSEC source: 0000950170-24-001227 · ownership.xml · nonDerivative · entry 1 Bruno Lawrence · CIK 0001730336 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 164,103 Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 17:47 UTC |
Daniels KevinCAO & Treasurer
|
Exercise / conversionPerformance Shares · Derivative | 7,200 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001245 · ownership.xml · derivative · entry 3 Daniels Kevin · CIK 0001740507 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,200 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. All requirements for 100% vesting have been met and thus the restricted shares vested on Decmeber 31, 2023 at the conclusion of the performance period. F1 · derivative.expiration_date: These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. All requirements for 100% vesting have been met and thus the restricted shares vested on Decmeber 31, 2023 at the conclusion of the performance period. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 17:47 UTC |
Daniels KevinCAO & Treasurer
|
Exercise / conversionCommon Stock | 7,200 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001245 · ownership.xml · nonDerivative · entry 2 Daniels Kevin · CIK 0001740507 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,949 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 17:47 UTC |
Daniels KevinCAO & Treasurer
|
Tax withholdingCommon Stock | 2,769 | $17.66 | $48,900.54 |
DisclosureSEC source: 0000950170-24-001245 · ownership.xml · nonDerivative · entry 1 Daniels Kevin · CIK 0001740507 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,180 Read SEC document |
| December 31, 2023 Filed Jan 3, 2024 17:46 UTC | Exercise / conversionPerformance Shares · Derivative | 14,674 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001244 · ownership.xml · derivative · entry 3 Gresham Gwendolyn · CIK 0001842114 · SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,674 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. The Company finished in the 81st percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2023. Excess shares that could vest above the 75th percentile are subject to an absolute total shareholder return modifier, which was negative over the relevant performance period, thereby reducing the number of such shares eligible to vest by one-half. Therefore, the performance criteria and requirements for vesting have been satisfied at 106.25% of the target award level, and such number of shares vested on December 31, 2023. F1 · derivative.expiration_date: These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4 filing on February 19, 2021. The Company finished in the 81st percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2023. Excess shares that could vest above the 75th percentile are subject to an absolute total shareholder return modifier, which was negative over the relevant performance period, thereby reducing the number of such shares eligible to vest by one-half. Therefore, the performance criteria and requirements for vesting have been satisfied at 106.25% of the target award level, and such number of shares vested on December 31, 2023. Read SEC document |
|
| December 31, 2023 Filed Jan 3, 2024 17:46 UTC | Exercise / conversionCommon Stock | 14,674 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001244 · ownership.xml · nonDerivative · entry 2 Gresham Gwendolyn · CIK 0001842114 · SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
|
| December 31, 2023 Filed Jan 3, 2024 17:46 UTC | Tax withholdingCommon Stock | 5,643 | $17.66 | $99,655.38 |
DisclosureSEC source: 0000950170-24-001244 · ownership.xml · nonDerivative · entry 1 Gresham Gwendolyn · CIK 0001842114 · SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,092 Read SEC document |
|
| December 31, 2023 Filed Jan 8, 2024 19:50 UTC Amendment |
Tattoli Mark DamianSVP, Gen Counsel & Secretary
|
Tax withholdingCommon Stock | 2,716 | $17.66 | $47,964.56 |
DisclosureSEC source: 0000950170-24-002893 · ownership.xml · nonDerivative · entry 1 Tattoli Mark Damian · CIK 0001872069 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,376.621 F1 · shares: The original Form 4, filed on January 3, 2024, is being amended by this Form 4 amendment to correct an administrative error of the issuer, whereupon the number of shares withheld to satisfy tax withholding obligations upon vesting of certain restricted performance shares was misreported as 2,654 shares. The corrected transaction reflects an increase of 62 shares withheld by the issuer as a result such vesting and a corresponding reduction in the number of shares beneficially owned by the reporting person. Read SEC document |
| December 31, 2023 Filed Jan 8, 2024 14:49 UTC Amendment |
Hill Christopher ScottSVP & CFO
|
Tax withholdingCommon Stock | 14,195 | $17.66 | $250,683.70 |
DisclosureSEC source: 0000950170-24-002890 · ownership.xml · nonDerivative · entry 1 Hill Christopher Scott · CIK 0001641315 · SVP & CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,049 F1 · shares: The original Form 4, filed on January 3, 2024, is being amended by this Form 4 amendment to correct an administrative error of the issuer, whereupon the number of shares withheld to satisfy tax withholding obligations upon vesting of certain restricted performance shares was misreported as 13,870 shares. The corrected transaction reflects an increase of 325 shares withheld by the issuer as a result such vesting and a corresponding reduction in the number of shares beneficially owned by the reporting person. Read SEC document |
| December 31, 2023 Filed Jan 8, 2024 19:41 UTC Amendment |
Bruno LawrenceDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 39,373 | $17.66 | $695,327.18 |
DisclosureSEC source: 0000950170-24-002882 · ownership.xml · nonDerivative · entry 1 Bruno Lawrence · CIK 0001730336 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,203 F1 · shares: The original Form 4, filed on January 3, 2024, is being amended by this Form 4 amendment to correct an administrative error of the issuer, whereupon the number of shares withheld to satisfy tax withholding obligations upon vesting of certain restricted performance shares was misreported as 38,473 shares. The corrected transaction reflects an increase of 900 shares withheld by the issuer as a result such vesting and a corresponding reduction in the number of shares beneficially owned by the reporting person. Read SEC document |
| December 31, 2023 Filed Jan 8, 2024 14:50 UTC Amendment |
Daniels KevinCAO & Treasurer
|
Tax withholdingCommon Stock | 2,834 | $17.66 | $50,048.44 |
DisclosureSEC source: 0000950170-24-002892 · ownership.xml · nonDerivative · entry 1 Daniels Kevin · CIK 0001740507 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,115 F1 · shares: The original Form 4, filed on January 3, 2024, is being amended by this Form 4 amendment to correct an administrative error of the issuer, whereupon the number of shares withheld to satisfy tax withholding obligations upon vesting of certain restricted performance shares was misreported as 2,769 shares. The corrected transaction reflects an increase of 65 shares withheld by the issuer as a result such vesting and a corresponding reduction in the number of shares beneficially owned by the reporting person. Read SEC document |
| December 31, 2023 Filed Jan 8, 2024 14:47 UTC Amendment | Tax withholdingCommon Stock | 5,775 | $17.66 | $101,986.50 |
DisclosureSEC source: 0000950170-24-002886 · ownership.xml · nonDerivative · entry 1 Gresham Gwendolyn · CIK 0001842114 · SVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,960 F1 · shares: The original Form 4, filed on January 3, 2024, is being amended by this Form 4 amendment to correct an administrative error of the issuer, whereupon the number of shares withheld to satisfy tax withholding obligations upon vesting of certain restricted performance shares was misreported as 5,643 shares. The corrected transaction reflects an increase of 132 shares withheld by the issuer as a result such vesting and a corresponding reduction in the number of shares beneficially owned by the reporting person. Read SEC document |
|
| December 29, 2023 Filed Jan 3, 2024 22:50 UTC |
Tattoli Mark DamianSVP, Gen Counsel & Secretary
|
Exercise / conversionPerformance Shares · Derivative | 6,900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-001250 · ownership.xml · derivative · entry 5 Tattoli Mark Damian · CIK 0001872069 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4A filing on October 6, 2021. All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2023 at the conclusion of the performance period. F1 · derivative.expiration_date: These shares were awarded as restricted performance shares in February 2021, as disclosed in the Reporting Person's Form 4A filing on October 6, 2021. All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2023 at the conclusion of the performance period. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:54 UTC |
Tattoli Mark DamianSVP, Gen Counsel & Secretary
|
Exercise / conversionRestricted Shares · Derivative | 160 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-067809 · ownership.xml · derivative · entry 5 Tattoli Mark Damian · CIK 0001872069 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,370 Underlying: Common Stock · 160 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F2 · balance_after: Multiple restricted share grants are included in this total. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:54 UTC |
Tattoli Mark DamianSVP, Gen Counsel & Secretary
|
Exercise / conversionCommon Stock | 160 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-067809 · ownership.xml · nonDerivative · entry 2 Tattoli Mark Damian · CIK 0001872069 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,254.621 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 21:54 UTC |
Tattoli Mark DamianSVP, Gen Counsel & Secretary
|
Tax withholdingCommon Stock | 62 | $18.07 | $1,120.34 |
DisclosureSEC source: 0000950170-23-067809 · ownership.xml · nonDerivative · entry 1 Tattoli Mark Damian · CIK 0001872069 · SVP, Gen Counsel & Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,192.621 Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 16:51 UTC |
Daniels KevinCAO & Treasurer
|
Exercise / conversionRestricted Shares · Derivative | 140 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-067805 · ownership.xml · derivative · entry 3 Daniels Kevin · CIK 0001740507 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 140 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.exercise_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. F1 · derivative.expiration_date: The Restricted Shares vest annually over six years on the anniversary of the grant date in the amount of 1/6th of the grant total, provided the reporting person remains in continuous service on each such vesting date. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 16:51 UTC |
Daniels KevinCAO & Treasurer
|
Exercise / conversionCommon Stock | 140 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-23-067805 · ownership.xml · nonDerivative · entry 2 Daniels Kevin · CIK 0001740507 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2023 Filed Dec 4, 2023 16:51 UTC |
Daniels KevinCAO & Treasurer
|
Tax withholdingCommon Stock | 54 | $18.07 | $975.78 |
DisclosureSEC source: 0000950170-23-067805 · ownership.xml · nonDerivative · entry 1 Daniels Kevin · CIK 0001740507 · CAO & Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,749 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.